Latest news
Palforzia Discontinuation Ends Only FDA-Approved Peanut OIT - HCPLiveHCPLive · Fri, 07 Aug 2026 12:01:05 GMTPalforzia Discontinued, Ending the Only FDA-Approved Peanut OIT Option - HCPLiveHCPLive · Fri, 31 Jul 2026 12:04:06 GMTOmalizumab beats multiallergen oral immunotherapy in multifood allergy trial - News-MedicalNews-Medical · Thu, 30 Jul 2026 07:00:00 GMT